## **Core Concept**
Polycythemia in newborns is a condition characterized by an excessive number of red blood cells, which can lead to increased blood viscosity and potential complications. Hematocrit (Hct) levels are a critical measure for diagnosing polycythemia. The venous hematocrit is specifically used for this diagnosis because it reflects the red blood cell mass more accurately than capillary hematocrit.

## **Why the Correct Answer is Right**
The correct diagnosis of polycythemia in newborns is made when the venous hematocrit level exceeds 65%. This threshold is crucial because values above this indicate an increased risk of complications such as hyperviscosity syndrome. The mechanism behind polycythemia involves an increase in red blood cell production, which can be primary (polycythemia vera) or secondary due to various factors like chronic hypoxia. In newborns, polycythemia can lead to serious complications, including respiratory distress, cyanosis, and increased risk of thrombosis.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Less than 55% is considered normal for newborns and does not indicate polycythemia.
- **Option B:** While values around 60% might be slightly elevated, they do not meet the threshold for diagnosing polycythemia in newborns.
- **Option D:** A hematocrit level greater than 70% would indeed indicate polycythemia but is not the threshold for diagnosis.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that the diagnosis of polycythemia in newborns requires a venous hematocrit level greater than 65%. Newborns with hematocrit levels in this range may require monitoring and possibly intervention to prevent complications. It's also important to differentiate between capillary and venous hematocrit levels, as capillary values can be higher due to local factors.

## **Correct Answer:** . 65%